For most people, the safest answer is no, not without clinical guidance and a confirmed reason
Genetic Factors: Some individuals have MTHFR gene mutations, making it incredibly difficult to process synthetic B12
Its preservative properties support laboratory protocols that require multiple withdrawals while helping maintain the quality of the reconstituted solution
All of these constituents are thoroughly mixed to form a uniform and consistent drug formulation
(Outlines contraindications for niacin therapy, including active peptic ulcer disease, active liver disease with elevated enzymes, hypersensitivity to niacin, and arterial bleeding, as well as monitoring recommendations for blood pressure, glucose, uric acid, etc., due to niacins systemic effects)